<VariationArchive RecordType="classified" VariationID="625638" VariationName="GRCh37/hg19 9q34.11(chr9:130335766-130517907)" VariationType="copy number loss" Accession="VCV000625638" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-06" DateCreated="2019-04-22" MostRecentSubmission="2019-04-22">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="613942" VariationID="625638">
      <GeneList>
        <Gene Symbol="CFAP157" FullName="cilia and flagella associated protein 157" GeneID="286207" HGNC_ID="HGNC:27843" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>9q34.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="127706988" stop="127716002" display_start="127706988" display_stop="127716002" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="130469270" stop="130476302" display_start="130469270" display_stop="130476302" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="NIBAN2" FullName="niban apoptosis regulator 2" GeneID="64855" HGNC_ID="HGNC:25282" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>9q34.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="127505343" stop="127579031" display_start="127505343" display_stop="127579031" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="130267617" stop="130341267" display_start="130267617" display_stop="130341267" Strand="-" />
          </Location>
          <OMIM>614045</OMIM>
        </Gene>
        <Gene Symbol="PTRH1" FullName="peptidyl-tRNA hydrolase 1 homolog" GeneID="138428" HGNC_ID="HGNC:27039" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>9q34.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="127694150" stop="127715676" display_start="127694150" display_stop="127715676" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="130476226" stop="130477935" display_start="130476226" display_stop="130477935" Strand="-" />
          </Location>
        </Gene>
        <Gene Symbol="SH2D3C" FullName="SH2 domain containing 3C" GeneID="10044" HGNC_ID="HGNC:16884" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>9q34.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="127738317" stop="127778666" display_start="127738317" display_stop="127778666" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="130500595" stop="130541047" display_start="130500595" display_stop="130541047" Strand="-" />
          </Location>
          <OMIM>604722</OMIM>
        </Gene>
        <Gene Symbol="STXBP1" FullName="syntaxin binding protein 1" GeneID="6812" HGNC_ID="HGNC:11444" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>9q34.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="127611912" stop="127696029" display_start="127611912" display_stop="127696029" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="130374485" stop="130454994" display_start="130374485" display_stop="130454994" Strand="+" />
          </Location>
          <OMIM>602926</OMIM>
          <Haploinsufficiency last_evaluated="2013-06-20" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=STXBP1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2013-06-20" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=STXBP1">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="TOR2A" FullName="torsin family 2 member A" GeneID="27433" HGNC_ID="HGNC:11996" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>9q34.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="127731524" stop="127735294" display_start="127731524" display_stop="127735294" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="130493802" stop="130497627" display_start="130493802" display_stop="130497627" Strand="-" />
          </Location>
          <OMIM>608052</OMIM>
        </Gene>
        <Gene Symbol="TTC16" FullName="tetratricopeptide repeat domain 16" GeneID="158248" HGNC_ID="HGNC:26536" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>9q34.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="127716079" stop="127731590" display_start="127716079" display_stop="127731590" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="130478357" stop="130493878" display_start="130478357" display_stop="130493878" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>GRCh37/hg19 9q34.11(chr9:130335766-130517907)</Name>
      <VariantType>copy number loss</VariantType>
      <Location>
        <CytogeneticLocation>9q34.11</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" innerStart="130335766" innerStop="130517907" display_start="130335766" display_stop="130517907" variantLength="182142" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.(?_130335766)_(130517907_?)del" Assembly="GRCh37">
            <Expression>NC_000009.11:g.(?_130335766)_(130517907_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="GRCh37/hg19 9q34.11(chr9:130335766-130517907) AND Developmental and epileptic encephalopathy, 4" Accession="RCV000767646" Version="1">
        <ClassifiedConditionList TraitSetID="1863">
          <ClassifiedCondition DB="MedGen" ID="C2677326">Developmental and epileptic encephalopathy, 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-11-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2018-11-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-04-22" MostRecentSubmission="2019-04-22">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="1863" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1178" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">STXBP1-Related Epileptic Encephalopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy, 4</ElementValue>
                <XRef ID="MONDO:0012812" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Early infantile epileptic encephalopathy 4</ElementValue>
                <XRef ID="Epileptic+encephalopathy%2C+early+infantile%2C+4/8343" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DEE4</ElementValue>
                <XRef Type="MIM" ID="612164" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12900" />
                <XRef ID="12900" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">STXBP1 encephalopathy with epilepsy is characterized by early-onset encephalopathy with epilepsy (i.e., moderate-to-severe intellectual disability, refractory seizures, and ongoing epileptiform activity). The median age of onset of seizures is six weeks (range 1 day to 13 years). Seizure types can include infantile spasms; generalized tonic-clonic, clonic, or tonic seizures; and myoclonic, focal, atonic, and absence seizures. Epilepsy syndromes can include Ohtahara syndrome, West syndrome, Lennox-Gaustaut syndrome, and Dravet syndrome (not SCN1A-related), classic Rett syndrome (not MECP2-related), and atypical Rett syndrome (not CDKL5-related). The EEG is characterized by focal epileptic activity, burst suppression, hypsarrhythmia, or generalized spike-and-slow waves. Other findings can include abnormal tone, movement disorders (especially ataxia and dystonia), and behavior disorders (including autism spectrum disorder). Feeding difficulties are common.</Attribute>
                <XRef ID="NBK396561" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27905812</ID>
                <ID Source="BookShelf">NBK396561</ID>
              </Citation>
              <XRef ID="1934" DB="Orphanet" />
              <XRef ID="33069" DB="Orphanet" />
              <XRef ID="599373" DB="Orphanet" />
              <XRef ID="C2677326" DB="MedGen" />
              <XRef ID="MONDO:0012812" DB="MONDO" />
              <XRef Type="MIM" ID="612164" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1761551" SubmissionDate="2019-04-01" DateLastUpdated="2019-04-22" DateCreated="2019-04-22">
        <ClinVarSubmissionID localKey="ES202|OMIM:612164" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000898268" DateUpdated="2019-04-22" DateCreated="2019-04-22" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-11-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG CNV Guidelines, 2011</Attribute>
          <Citation>
            <ID Source="PubMed">21681106</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Oligo array</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SecondaryFinding">no</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>copy number loss</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="9" innerStart="130335766" innerStop="130517907" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="612164" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5380435</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1761551" TraitType="Disease" MappingType="XRef" MappingValue="612164" MappingRef="OMIM">
        <MedGen CUI="C2677326" Name="Developmental and epileptic encephalopathy, 4" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

